Teresa Brophy Bair - 27 Jan 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Legal Officer
Signature
Teresa Bair
Issuer symbol
KURA
Transactions as of
27 Jan 2026
Net transactions value
-$94,828
Form type
4
Filing time
27 Jan 2026, 21:35:02 UTC
Previous filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bair Teresa Brophy Chief Legal Officer C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO Teresa Bair 27 Jan 2026 0001813058

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale $34,655 -4,096 -1.7% $8.46 234,043 27 Jan 2026 Direct F1
transaction KURA Common Stock Sale $19,756 -2,335 -1% $8.46 231,708 27 Jan 2026 Direct F2
transaction KURA Common Stock Sale $40,417 -4,777 -2.1% $8.46 226,931 27 Jan 2026 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25.
F2 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.
F3 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.